$BMM

Blue Moon Metals (BMM) announced an investor rights agreement with Elmet, granting board representation and other privileges. BMM has no revenue, trades at a high P/S ratio, and has a GF Score of 35/100. Two premium gurus hold shares, with one increasing their position. BMM is an exploration-stage mining company with projects in the U.S. and Norway, valued at $370M.

Blue Orca and Iceberg Research published reports on EquipmentShare.com (EQPT) and Deep Fission (FISN), alleging financial and operational issues. EquipmentShare disputes the claims. Viceroy and Scorpion Capital raised concerns about Blue Moon Metals (BMM) and Twist Bioscience (TWST). Several companies, including Corcept Therapeutics (CORT), Nutanix (NTNX), and Zscaler (ZS), reported executive departures. Michael Burry warned of $3 trillion in AI-related commitments across major tech firms.

Blue Moon Metals reported new assay results from its Springer Tungsten project, including a 7m interval grading 1.28% WO₃. The company aims to restart the mine by Q4 2027. Shares rose 3% to $7.72. BLM approved new drilling on public land. Scotiabank analyst views results as mildly positive.

The U.S. seeks to secure tungsten supply, currently dominated by China. Blue Moon Metals (TSXV: MOON, NASDAQ: BMM), The Elmet Group (NASDAQ: ELMT), and EQ Resources (ASX: EQR) announced a strategic agreement to develop the Springer Tungsten Complex in Nevada. The U.S. Department of War invested $450 million, with $150 million allocated to the project. The companies aim to restart production by Q4 2027, addressing the U.S. tungsten shortage.

The Pentagon committed $450M to Elmet (ELMT) for tungsten supply chain expansion, including a $150M investment in Blue Moon Metals' (BMM) Springer project in Nevada. The U.S. aims to reduce reliance on China, which dominates global tungsten supply. Elmet will control the APT plant, with production expected to restart in 2028.

The U.S. Department of Defense is investing $450M in Elmet Group, with $150M allocated to Blue Moon Metals' Springer tungsten complex in Nevada. Blue Moon will receive $50M in tungsten concentrate prepayment and $25M in equity investment, while Elmet will invest $75M in a joint venture to restart the APT plant. Analysts view the deal positively, with shares of Blue Moon rising 6.5% to C$8.08. The Pentagon aims to secure domestic tungsten supply chains, as China controls about 85% of global suppl

Elmet Group (ELMT) shares surged 50.6% to $24.39 after announcing plans to use a $450M DoD investment to boost tungsten supply. Other stocks gaining include Rum Group (RUM) +15%, Tyra Biosciences (TYRA) +14.5%, and Roblox (RBLX) +8.7% after price target raises.

Blue Moon Metals, The Elmet Group, and EQ Resources agreed to invest $150-$175M in the Springer Tungsten Complex in Nevada. The deal includes a joint venture, equity investment, and supply agreements. The U.S. Department of War also invested $450M in TEG, with $150M earmarked for this project. Blue Moon aims to restart production by Q4 2027, supporting the U.S. tungsten supply chain.

China dominates tungsten supply, with limited production outside the country. U.S. faces a shortage, relying on imports and recycled material. Demand is expected to grow, potentially driving up prices. Blue Moon Metals (TSXV: MOON, NASDAQ: BMM) acquired land and water rights near its Springer mine for $8 million. Almonty Industries (NASDAQ: ALM, TSX: AII) began processing at its Sangdong Mine. American Tungsten (TSXV: TUNG, OTCQX: TUNGF) advances exploration at its Ima Mine.

Tungsten prices surged 622% in 2025, driven by U.S. defense supply chain rules. Blue Moon Metals (TSXV: MOON, NASDAQ: BMM) secured permits for its Nevada tungsten project, aiming for 2027 production. Almonty Industries (NASDAQ: ALM, TSX: AII) began processing at its South Korea mine. American Tungsten (TSXV: TUNG, OTCQX: TUNGF) and Fox Tungsten (TSXV: FOXT) also advanced projects. Investors may monitor these companies for potential opportunities.